FREQUENCY THERAP(FREQ) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, today reported financial results for the third quarter of 2024 and provided an update on its recent progress and anticipated milestones. "Korro is delivering across key scientif ...